Advertisement

Topics

Kelley Bernheim Dolinsky, LLC Company Profile

13:44 EDT 18th June 2018 | BioPortfolio


News Articles [21 Associated News Articles listed on BioPortfolio]

VBL Therapeutics Announces the Appointments of Susan Kelley and David ...

VBL Therapeutics , today announced the appointments of both David Hastings and Susan Kelley, M.D. to its Board of Directors. Susan L. Kelley, M.D. is an oncologist with extensive experience in drug de...

Flexion Therapeutics Promotes Scott Kelley to Chief Medical Officer

Scott Kelley has been appointed chief medical officer of Flexion Therapeutics (NASDAQ: FLXN). Kelley was previously vice president of medical affairs for the Burlington, MA, drug developer. He succeed...

Kelley Blue Book Answers Growing Demand for Certified Vehicle Pricing with Launch of New CPO ...

Now available on KBB.com and on Participating Dealer websites, Kelley Blue Book® Price Advisor for CPO is based on recent certified vehicle sales transactions, updated Read more...

VBL Therapeutics Announces the Appointments of Susan Kelley and David Hastings to Its Board of Directors

Senior pharmaceutical executives with extensive experience in immuno-oncology, drug development, commercializing oncology medications and finance TEL AVIV, Israel, Jan. 03, 2018 (GLOBE NEWSWIRE...

Apexian Pharmaceuticals’ Dr. Mark Kelley Recognized as an Outstanding Researcher at Indiana University/Purdue University IUPUI

Apexian Pharmaceuticals, a clinical-stage biotechnology company focused on developing safe and effective therapy for patients with high unmet medical needs, is pleased to announce...

HCC Trials Spur Treatment Landscape Forward

R. Kate Kelley, MD, discusses the incidence of and risk factors for HCC, and emphasizes the sequence of clinical trials that characterized the field in 2017.

Subaru Wins Most Trusted Brand In Kelley Blue Book's KBB. ...

"We are extremely proud to accept this award for the fourth year in a row," said Thomas J. Doll, chief executive officer, Subaru of Read more...

Former Department of Commerce Trade Enforcement Official Joins Kelley Drye

Mr. Lorentzen spent nearly eight years as the Principal Deputy Assistant Secretary of Commerce for Enforcement & Compliance (E&C).  He led a staff of three Read more...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Open-Label Placebo for the Treatment of Depression

Open label placebo treatment has been tried for irritable bowel syndrome (Kaptchuk et al, 2010), where three weeks of open label placebo proved superior to a wait-listed control group. Ano...

More Information about "Kelley Bernheim Dolinsky, LLC" on BioPortfolio

We have published hundreds of Kelley Bernheim Dolinsky, LLC news stories on BioPortfolio along with dozens of Kelley Bernheim Dolinsky, LLC Clinical Trials and PubMed Articles about Kelley Bernheim Dolinsky, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kelley Bernheim Dolinsky, LLC Companies in our database. You can also find out about relevant Kelley Bernheim Dolinsky, LLC Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record